Livingstone Chishimba specialises in aspergillosis (amongst other things) and works at the National Aspergillosis Centre, Manchester, UK.
This is a regular monthly support meeting held at the NAC for patients living with aspergillosis.
Livingstone Chishimba Q & A session with National Aspergillosis Centre patien...Graham Atherton
Dr Livingstone Chishimba is a specialist aspergillosis doctor working at the National Aspergillosis Centre, Manchester, UK.
This is the second session he has run discussing & answering questions from our patients and those who are members of our support groups online
http://uk.groups.yahoo.com/group/AspergillusSupport/
Involving patients in their own treatment & research Aspergillosis Patients M...Graham Atherton
Fungal Research Trust trustee Derek Stewart talks about the benefits of involving patients in research and the potential benefits to their own health care
Livingstone Chishimba Q & A session with National Aspergillosis Centre patien...Graham Atherton
Dr Livingstone Chishimba is a specialist aspergillosis doctor working at the National Aspergillosis Centre, Manchester, UK.
This is the second session he has run discussing & answering questions from our patients and those who are members of our support groups online
http://uk.groups.yahoo.com/group/AspergillusSupport/
Involving patients in their own treatment & research Aspergillosis Patients M...Graham Atherton
Fungal Research Trust trustee Derek Stewart talks about the benefits of involving patients in research and the potential benefits to their own health care
Aspergillosis Patients Support Outreach Meeting London June 2011 - David DenningGraham Atherton
Talk given to the Aspergillosis Patients Outreach Meeting in London entitled "ABPA and SAFS" by National Aspergillosis Centre Director Professor David Denning
The job of a Product Manager within the fashion and retail industry is to oversee the product planning and execution throughout the fashion product lifecycle. Oversee the Product Development team and production team as well as working closely with all stakeholders.
PRESENTASI KARYA ILMIAH JUNK FOOD_AMRINA ROSADA & VINI WULANDARIamrinarosada7x
Untuk melihat tulisan lebih jelas, maka silahkan di unduh. Karena tulisan banyak tertimpa dengan efek-efek. Jika kurang jelas, Anda bisa email saya di: amrina7x@gmail.com. Terima kasih telah berkunjung.
First clinocopathological conferece presentation by
Awab Hassan
Ammara Mahroof
Elishbah Naveed
Ali Raza
Abila Shakor
Bahroz Khan
The pathophysiology along with the treatment and drugs used in asthma are briefly covered.
Kray Protection - Autonomous agricultural drones for crop dustingArtem Sorokin
Crop protection with ground application takes up to 20% of crop value due to trampling and requires a big equipment capex. Aerial application with currently available aviation services can cut these costs roughly in half.
Nevertheless, these services have severe disadvantages - they are outsourced (only 22% of US&C farms, the biggest ones, have own aerial application capabilities), too expensive ($25 to $50 per hectare), limited (a lot of fields cannot be processed due to size and form, or obstacles), prone to capacity shortages (many farmers need the same service in the same time, so shortages are practically inevitable).
Besides the crop protection needs to be applied in a particular moment of the crop or pest life cycle (often window is limited to 1 day) – so being able to make it exactly when it is needed is very important and not possible with current states of things in any way of application.
The very important is that application of crop protection impacts up to 70% of yield, so outsourcing it to aerial services leads to limited control.
Therefore, the reliable, inexpensive, in-house, productive enough aerial solution for crop protection application could solve severe pain experienced by farmers with middle-sized acreage.
Aspergillosis Patient Support Meeting July 2011 - Sue HowardGraham Atherton
2 hour support meeting for patients & carers that live with aspergillosis.
Main speaker is Dr Sue Howard of Manchester University and the National Aspergillosis Centre
Bronchial embolisation to treat bleeding caused by chronic pulmonary aspergil...Graham Atherton
Radiology Consultant at the National Aspergillosis Centre, Ray Ashleigh talks to our patients support group about embolisation as a treatment for haemoptysis (bleeding) caused by chronic pulmonary aspergillosis and aspergilloma.
Aspergillosis Patients Support Outreach Meeting London June 2011 - David DenningGraham Atherton
Talk given to the Aspergillosis Patients Outreach Meeting in London entitled "ABPA and SAFS" by National Aspergillosis Centre Director Professor David Denning
The job of a Product Manager within the fashion and retail industry is to oversee the product planning and execution throughout the fashion product lifecycle. Oversee the Product Development team and production team as well as working closely with all stakeholders.
PRESENTASI KARYA ILMIAH JUNK FOOD_AMRINA ROSADA & VINI WULANDARIamrinarosada7x
Untuk melihat tulisan lebih jelas, maka silahkan di unduh. Karena tulisan banyak tertimpa dengan efek-efek. Jika kurang jelas, Anda bisa email saya di: amrina7x@gmail.com. Terima kasih telah berkunjung.
First clinocopathological conferece presentation by
Awab Hassan
Ammara Mahroof
Elishbah Naveed
Ali Raza
Abila Shakor
Bahroz Khan
The pathophysiology along with the treatment and drugs used in asthma are briefly covered.
Kray Protection - Autonomous agricultural drones for crop dustingArtem Sorokin
Crop protection with ground application takes up to 20% of crop value due to trampling and requires a big equipment capex. Aerial application with currently available aviation services can cut these costs roughly in half.
Nevertheless, these services have severe disadvantages - they are outsourced (only 22% of US&C farms, the biggest ones, have own aerial application capabilities), too expensive ($25 to $50 per hectare), limited (a lot of fields cannot be processed due to size and form, or obstacles), prone to capacity shortages (many farmers need the same service in the same time, so shortages are practically inevitable).
Besides the crop protection needs to be applied in a particular moment of the crop or pest life cycle (often window is limited to 1 day) – so being able to make it exactly when it is needed is very important and not possible with current states of things in any way of application.
The very important is that application of crop protection impacts up to 70% of yield, so outsourcing it to aerial services leads to limited control.
Therefore, the reliable, inexpensive, in-house, productive enough aerial solution for crop protection application could solve severe pain experienced by farmers with middle-sized acreage.
Aspergillosis Patient Support Meeting July 2011 - Sue HowardGraham Atherton
2 hour support meeting for patients & carers that live with aspergillosis.
Main speaker is Dr Sue Howard of Manchester University and the National Aspergillosis Centre
Bronchial embolisation to treat bleeding caused by chronic pulmonary aspergil...Graham Atherton
Radiology Consultant at the National Aspergillosis Centre, Ray Ashleigh talks to our patients support group about embolisation as a treatment for haemoptysis (bleeding) caused by chronic pulmonary aspergillosis and aspergilloma.
Dr Mike Bromley talks about the role of Manchester University in the research and development of new antifungal drugs, followed by Dr Iain Page talking about our research projects in Africa that have the potential to reveal much larger numbers of people suffering from Chronic Pulmonary Aspergillosis (CPA) than is currently thought.
Gillian Barrie syndrome An autoimmune disease,
this presentation is a case discussion for actual case includes: demographic data, current history, past history, chief complaint, prognosis, medications, medical treatment, nursing management, disease pathophysiology.
Peripheral Neuropathy: Will it ever go away? Problems, Causes, SolutionsFight Colorectal Cancer
Have you ever experienced peripheral neuropathy? Did it feel like a numbness or tingling in your hands or feet? Did it last several weeks, or several years? Join us, as Cindy S. Tofthagen, PhD, ARNP, AOCNP, University of South Florida College of Nursing Assistant Professor and Concentration Director of Oncology, will discuss this important topic and ways to manage it.
Although peripheral neuropathy is a known common side effect of some chemotherapy regimens, there are many different types of peripheral neuropathy, and many different causes. Cindy will explain exactly what it is that's happening, why it happens, and what causes it to happen. And then, most importantly, will provide tips on the best ways to manage it. You're not going to want to miss this!
Danielle Yuill: Giving patients a VOICE project (Patients helping in research at NAC) http://www.uhsm.nhs.uk/racrf/Pages/involved.aspx.
NB this meeting was confidential so audio is not broadcast in the second part of this support meeting.
A discussion to collect ideas and discuss the forthcoming new handout for the purpose of communicating our support with patients who do not use computers
Aspergillosis Support Group Christmas Quiz 2013Graham Atherton
The December meeting of the Aspergillosis Support Group for Patients & Carers is a quiz played for the David MacIntyre Trophy. Questions are based around the information presented in the previous years meeting and other information about aspergillosis. See how you do!
Poet in Residence Caroline Hawkridge talks about our achievements in holding events to raise awareness of fungal infections using poetry written with patients & carers at earlier meetings.
Graham Atherton talked about GAFFI and about how antifungal drugs work to kill fungal infections
Involving Patients (and carers) in research at NWLC & NACGraham Atherton
Danielle Yuill tells us about her project to discover how best to involve patients and carers in research at the North West Lung Centre & National Aspergillosis Centre - amd not just reviewing grant requests and providing tissue samples.
Graham Atherton takes us through some of the many features & structures we can see in a lung x-ray - what does aspergillosis look like??.
Comparing parts of UK & US Healthcare systems, IgG explainedGraham Atherton
NAC consultant Eavan Muldoon introduces herself as our new medic and talks a little about her background, part of which was spent at Tufts Medical Centre, Boston, USA. Then Graham Atherton talks about IgG, what they are and how they work.
Management of Chronic Pulmonary Aspergillosis and IgE for the LaypersonGraham Atherton
Professor Denning summarises how we manage CPA at the National Aspergillosis Centre, what we have learned, what we are still learning.
Graham Atherton describes IgE and how it affects Aspergillosis
Julia Hamer, Directorate Manager of Respiratory Medicine at University Hospital South Manchester talks to our patients about the new structure of the NHS and how it effects us.
Graham Atherton talks about health precautions when we are experiencing a heatwave and speaks of a subject suggested by patients: Adverse effects of medications.
Steve Webster of the Manchester Carers Centre, UK talks about the support and services offered by the centre in Manchester and the other centres throughout the UK. Graham Atherton talks about our progress in the understanding of the health effects caused by damp homes, and how to avoid them!
Chronic illness health psychologist Alison Wearden talks about how stress effects our health and our recovery from illness, and specialist physiotherapist Phil Langridge talks about breathlessness and what we can do to control it.
Graham Atherton discusses gardening for those with allergies, the signs of heart disorder to be aware of if you are taking itraconazole and advice on travel.
Creative Writing Projects at the National Aspergillosis CentreGraham Atherton
Caroline is the Writer-in Residence at the National Aspergillosis Centre. We are using creative writing as a means to open up communication between established relationships such as those between clinical professionals and the patient.
Maintaining or Improving your health status in CPA (Khaled Al-shair)Graham Atherton
Khaled summarises why many people do not improve as much as they could while being treated for chronic pulmonary aspergillosis, what they can do to help themselves if they are not already doing it.
Dr Libby Radcliffe talks about the aches & pains suffered by aspergillosis patients, the different causes and what can be done to reduce them. Professor Malcolm Richardson talks about the types of moulds we all come across every day and the damage they can cause in the wrong places. Dr Graham Atherton talks about the correct specification for facemasks used to reduce the inhalation of mould spores when carrying out routine daily tasks & hobbies.
Support meeting for aspergillosis patients with Paul Bowyer, Senior Scientist on recent advances in research on susceptibility to Chronic Pulmonary Aspergillosis
Cheryl Pearse, Specialist Nurse in Smoking Cessation at UHSM, Manchester gives the Aspergillosis Patients Meeting a presentation on giving up smoking. July 2012
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
National Aspergillosis Centre Doctor Livingstone Chishimba holds a Q&A session
1. LED BY GRAHAM ATHERTON SUPPORTED BY GEORGINA POWELL, MARIE KIRWAN & DEBBIE KENNEDY NAC CENTRE MANAGER CHRIS HARRIS TALK GIVEN BY LIVINGSTONE CHISHIMBA CLINICAL FELLOW AT THE NATIONAL ASPERGILLOSIS CENTRE NATIONAL ASPERGILLOSIS CENTRE UHSM MANCHESTER Support Meeting for Aspergillosis Patients Fungal Research Trust
2.
3. Patient meeting -Q &A Dr Livingstone Chishimba University Hospital of South Manchester
17. EU caseload of aspergillosis Immune dysfunction Frequency of aspergillosis Immune hyperactivity Frequency of aspergillosis Subacute Invasive Aspergilloma Chronic cavitary Chronic fibrosing Locally invasive . After Casadevall & Pirofski, Infect Immun 1999;67:3703 30,000 - 70,000 cases ~7,500 cases ABPA Severe asthma with fungal sensitisation Allergic sinusitis Acute Invasive
18.
19. Incidence of Cryptococcus gattii infection British Columbia, Canada Source: BC Centre for Disease Control 2007 Cases per 100,000 population Average incidence 1999–2006: Vancouver Island: 2.8 cases per 100,000 Mainland: 0.65 cases per 100,000
20. Likely ABPA caseload 1%+ of adult asthmatics attending clinic have ABPA In UK - ~5,000,000 with asthma, >3M adults In Europe - >17,000,000 adults with asthma ~ 150,000 adults with ABPA in Europe ~12% of those with CF have ABPA EU CF population ~150,000 = ~ 17,500 patients
44. Himalayan Challenge The Himalayan 100 Mile Stage Race has been describe as the 'most beautiful' and the 'toughest' marathon in the world. The Runners Times magazine ran an article on the marathon. Their opening line was: "There are lots of good reasons not to do the Himalayan 100 Mile Stage Race. The first three are that it’s really, really, really hard."